Enhancing R&D Effectiveness through Global ELN Deployment DVD
About the DVD:
Transitioning from a paper notebook to an ELN has proven advantages for data integrity, interoperability, analysis and management. ELNs have allowed different types and formats of research data to be stored in one place, and be accessed across departments, divisions and research sites, enabling enhanced consistency, efficiency and collaboration. As pharma strives to incorporate ELNs into existing workflows, questions remain about the best way to leverage this technology to enhance R&D’s effectiveness—what data should be stored in the ELN, who has access to it and when, how should this be rolled out to ensure a smooth transition?
This workshop presents case studies from early adapters and pharmaceutical leaders, each discussing the unique needs an ELN has addressed for their scientists, management and legal teams, and offering best practices and lessons learned in implementation.
About the Conference:
Bio-IT World Conference & Expo
Enabling Technology. Leveraging Data. Transforming Medicine.
The 2012 Expo plans to unite 2,000+ life sciences, pharmaceutical, clinical, healthcare, and IT professionals from 30+ countries. The Expo provides the perfect venue to share information and discuss enabling technologies that are driving biomedical research and the drug development process.
Since its debut in 2002, the annual Bio-IT World Conference & Expo has established itself as a premier event showcasing the myriad applications of IT and informatics to biomedical research and the drug discovery enterprise. Marking our 10th anniversary, the 2012 program will feature compelling talks from industry and academia on new trends in data generation, knowledge management, and information technology in life sciences and drug development. Bio-IT World Conference & Expo continues to expand with the addition of three new Tracks: Molecular Diagnostics Informatics, Open Source Solutions, and Cancer Informatics.
Spanning three days, the meeting includes 12 parallel conference tracks and 16 pre-conference workshops.
About the DVD:
Over 149 Minutes
Site License: $1380
Agenda At A Glance:
Enhancing R&D Effectiveness through Global ELN Deployment
- Integration of Information from ELN for Biologics (Ralph)
- ELN and contract research – bridging the data management chasm( Mike K )
- Overcoming challenges of the vendor / client partnership in a global ELN deployment (Mike K)
- Building a scientific workflow for ELN usage (Mike K)
- Knowledge-based optimization of bioprocess development (Sean)
- Improving formulations design through ELN (Sean)
Michael H. Elliott, CEO, Atrium Research & Consulting LLC
Biography: Michael Elliott is the founder, CEO, and chief analyst at market research and strategy consulting company Atrium Research & Consulting LLC. Mr. Elliott founded the company to provide educational content and consulting in laboratory informatics. Known for its in-depth analysis and converge, Atrium Research is the recognized leader in scientific information technology market analysis. Mr. Elliott's technology career began as a clinical research chemist developing bioanalytical methodologies. In 1983, he joined Perkin-Elmer Corporation, as a laboratory information and automation software technical consultant. His career progressed into positions that included LIMS sales, IT project manager, director of US operations, VP of worldwide marketing and product management, and division VP and general manager. In 2000, he joined Scientific Software, Inc. (now part of Agilent Technologies) as SVP responsible for worldwide operations. Mr. Elliott has authored multiple papers and research studies on laboratory informatics including the industry standard report on ELN. He also writes the bimonthly ELN column for Scientific Computing magazine and is also on its editorial review board.
Michael Kopach, Ph.D., Principal Research Scientist, Chemical Product R&D, Eli Lilly & Co
Biography: Dr. Kopach graduated from the University of Virginia in 1995 with a Ph.D. in organic chemistry, then completed a postdoc in natural product synthesis at Colorado State University under the guidance of Prof. A. I. Meyers. Dr. Kopach was then employed at Roche for 5 years at their manufacturing site located in Boulder, Colorado. While employed at Roche, Dr. Kopach's primary responsibilities included implementation of commercial processes for Nelfinar®, Fuzeon® and Xenical®. In 2001, Dr. Kopach joined Eli Lilly and Company and has led several multidisciplinary phase 1 to phase 3 R & D projects. In addition, Dr. Kopach has been business project leader for the global deployment of an electronic Laboratory Notebook at Eli Lilly and Company. More recently, Dr. Kopach has represented Eli Lilly and Company at the ACS Green Chemistry Institute® Pharmaceutical Roundtable where he presently serves as co-chair.
Ralph Haffner, Local Area Head, Research Informatics, F. Hoffmann-La Roche AG
Biography: Ralph graduated with a masters in Medical Informatics from the University of Heidelberg. He started his professional career in 1997 as a software engineer and consultant for Healthcare Information Systems. In 1999 he joined Roche as System Analyst for Workflow Systems. After several roles with increasing responsibility he was appointed to lead the Biologics Research Informatics Department in Penzberg Germany. In January 2011 he moved to the Roche headquarters in Basel, Switzerland where he is leading the Research Informatics Department supporting Small Molecules Research. His main expertise is in the area of Scientific Workflow Systems, LIMS, ELNs and Warehouses for Scientific Data.
Arturo Morales, Ph.D., Global Leader, NIBR Informatics & Technology Novartis Institutes for BioMedical Research Inc
Biography: Art received his BS in Biochemistry and Biophysics from Rensselaer (RPI) and his Ph.D. in Biology from MIT and then went to work as a computational biologist at Genome Therapeutics. He then went into a couple of small biotech startups where he built their informatics and IT infrastructures and then spent 4 years at Concert Pharmaceuticals managing Biology, IT and IS. Art came to Novartis ~1.5 years ago and is focused on rebuilding the enterprise data management infrastructure and processes to enable and accelerate research.
Ryan Bass, Senior Systems Engineer, Strategic Operations, Janssen Research & Development, Pharmaceutical Development & Manufacturing Sciences, Johnson & Johnson
Biography: Ryan is a Systems Engineer in the Pharmaceutical Development & Manufacturing Sciences division of Johnson & Johnson. He holds a Master's degree in Chemistry from Villanova University. Upon joining Johnson & Johnson Centocor in 2004, he worked extensively in formulation development of monoclonal antibodies and work with subcutaneous and nasal delivery devices. In 2010, Ryan joined Strategic Operations, a newly formed group within the organization. Using his scientific knowledge and laboratory background, his new focus is on strategic initiatives including modernization of R&D systems to streamline global knowledge transfer.
Sean D. Pitts, Amgen , P&PD Business & Resource Management
Biography: Sean Pitts has worked at Amgen for over 9 years in Quality Control (QC) and Research and Development (R&D). Sean currently leads a scientific resource group focused on knowledge management, data management, document management, training, and regulatory compliance. Previous to working at Amgen, Sean consulted at pharmaceutical companies including Genentech and Novartis. Sean's expertise in the validation of laboratory equipment and information systems is highlighted by leading efforts to implement systems such as LIMS, CDS, and ELN in both a QC and R&D setting. Sean received his B.S. in Chemical Engineering from the University of Colorado and his MBA from Pepperdine University Graziadio School of Business and Management.